Moderna got the FDA to change its mind and review its flu vaccine after some concessions
Moderna’s stock was surging after the FDA said it would review the biotech’s flu-vaccine candidate, a week after it had refused to do so.
Last updated: 2026-02-18 21:18:16 ET
Moderna’s stock was surging after the FDA said it would review the biotech’s flu-vaccine candidate, a week after it had refused to do so.
Trump says everyday Americans deserve a chance to buy higher-risk ‘alternative’ investments. Critics say this could lead to big losses for small i...
Two fish and chip shops in Fenland are trying lesser known varieties of fish as cod prices soar.
As calls for the former prince to cooperate with police become deafening, this may be the reckoning Andrew cannot outrunGordon Brown is a man who gets...
It is critical for key decisionmakers to keep in mind the symbiotic relationship between critical minerals and permanent magnets, Wade Senti writes.
Stocks have prospered while the world has plunged into disorder, an economist says. “Keep calm and carry on” may be the best investors can do.
At least for now, Paramount needs to work hard to change the hearts and minds of WBD investors about Netflix.
Before They Called It Mind Control, They Called It Secret Societies
Meditation isn’t thinking about nothing. New research reinforces that it's a mind-altering, dynamic state that promotes focus, learning, and well-be...